{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T18:33:11Z","timestamp":1786559591990,"version":"build-2736575974"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bone.2018.04.025","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T05:49:57Z","timestamp":1525326597000},"page":"173-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trial"],"prefix":"10.1016","volume":"112","author":[{"given":"Erik J.M.","family":"van Bommel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate T.","family":"de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrte","family":"Brands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke C.","family":"Heijboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"den Heijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille J.","family":"Serlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-6124","authenticated-orcid":false,"given":"Daniel H.","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2018.04.025_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2013.12.006","article-title":"Glucocorticoids and bone: local effects and systemic implications","volume":"25","author":"Henneicke","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2018.04.025_bb0010","first-page":"62","article-title":"Steroid diabetes: from mechanism to treatment?","volume":"72","author":"van Raalte","year":"2014","journal-title":"Neth. J. Med."},{"issue":"1","key":"10.1016\/j.bone.2018.04.025_bb0015","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-14-0584","article-title":"Endocrine role of bone: recent and emerging perspectives beyond osteocalcin","volume":"225","author":"Oldknow","year":"2015","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2018.04.025_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrendo.2012.201","article-title":"The role of osteocalcin in human glucose metabolism: marker or mediator?","volume":"9","author":"Booth","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2018.04.025_bb0025","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/dmrr.2668","article-title":"Bone remodelling markers in hypertensive patients with and without diabetes mellitus: link between bone and glucose metabolism","volume":"31","author":"Feldbrin","year":"2015","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"7","key":"10.1016\/j.bone.2018.04.025_bb0030","doi-asserted-by":"crossref","first-page":"E1173","DOI":"10.1210\/jc.2013-1203","article-title":"Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and beta-cell function in overweight adults","volume":"98","author":"Gower","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2018.04.025_bb0035","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1172\/JCI63377","article-title":"Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism","volume":"122","author":"Brennan-Speranza","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bone.2018.04.025_bb0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jbmr.5650030117","article-title":"Effects of short-term glucocorticoids on serum osteocalcin in healthy young men","volume":"3","author":"Godschalk","year":"1988","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2018.04.025_bb0045","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00125-011-2174-9","article-title":"Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial","volume":"54","author":"van Raalte","year":"2011","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.bone.2018.04.025_bb0050","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/jbmr.417","article-title":"Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism","volume":"26","author":"Yoshikawa","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.04.025_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bone.2014.07.008","article-title":"Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugs","volume":"67","author":"Mazziotti","year":"2014","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2018.04.025_bb0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/cen.13139","article-title":"Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis","volume":"85","author":"Celer","year":"2016","journal-title":"Clin. Endocrinol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218301790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218301790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T21:57:29Z","timestamp":1534888649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218301790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":12,"alternative-id":["S8756328218301790"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.04.025","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}